NEU30009 Neuropsychopharmacology Investigational Drug Case Study

NEU30009 Neuropsychopharmacology Investigational Drug Case Study

TITLE PAGE:

Title

Student Name:

Student Number:

Word Count:

Date:

After title page:

Title

INTRODUCTION: (The word introduction should be to the left of the page and in bold)

(Start generally and introduce the disease/disorder, treatments, and then the treatment you intend to assess) ~1000 words

METHODS: (The word methods should be to the left of the page and in bold)

Participants:

(Age, gender, and number of participants you plan to include)

Inclusion/Exclusion Criteria:

Primary Outcome Measure:

(This should be a detailed description of your cognitive and/or behavioural outcome with associated references)

Secondary Outcome Measure (if applicable):

(Can be cognitive/behavioural/neuroimaging/mood outcome)

Procedure:

(Describe exactly what participants will do on a testing day this can include tables or flow charts of the study design)

Analysis:

(Describe how you intend to analyse the data active treatment vs control; male vs female; change from baseline; and a basic description of you analysis technique t-test; repeated measures anova, etc)

CONCLUSION: (The word conclusion should be to the left of the page and in bold)

(Briefly summarise your research design and why it is important research that needs to be done)

REFERENCES:

Please use the Swinburne Harvard style referencing. Here is the link to the Swinburne Harvard style guide: https://www.swinburne.edu.au/library/referencing/harvard-style-guide/